Content by Cytiva

Luke Pase and Prof. Fujiwara discuss how new targeting strategies and scalable manufacturing approaches are advancing next-generation T cell therapies.

Expert researchers outline scalable approaches to improve cellular therapy production through standardized and automated workflows.

Manufacturing cell-based therapeutics requires a robust workflow from start to finish.

An improved chromatography membrane elution method helps scientists achieve higher yields of pure plasmid DNA.

By fine-tuning polishing conditions, scientists attain high titers of infectious lentiviral particles during purification.

Discover a scalable and flexible GMP-compliant workflow for producing plasmid DNA.

Collaboration combines Nuclera's eProtein Discovery System, which accelerates protein expression, purification and optimization, with Cytiva's Biacore SPR system, which characterizes molecular interactions

With the right guidance, researchers can select the appropriate protein purification workflow to meet their unique needs.

Discover tips for guiding drug development from discovery to the clinic.

Translational scientists employ surface plasmon resonance (SPR) to make informed decisions when choosing their lead antibody candidates. 

From sample preparation to real-time analyses, scientists embarking on protein research journeys need to equip themselves with technical knowledge.

Review tips to guide all stages of western blotting, from sample preparation to imaging and analysis.

Researchers use label-free surface plasmon resonance to measure affinity and binding kinetics in real time. 

Knowing what to focus on, what resources are available, and who to talk to for regulatory advice ahead of time can smooth the drug discovery journey.

Incorporating automation can be vital to overcoming scale-up obstacles associated with moving from discovery to manufacturing.